Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€60.80

€60.80

2.350%
1.4
2.350%
€144.31
 
10.07.25 / Tradegate WKN: 866931 / Symbol: NVO / Name: Novo Nordisk / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Novo Nordisk A/S ADR is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Novo Nordisk

sharewise wants to provide you with the best news and tools for Novo Nordisk, so we directly link to the best financial data sources.

News

Novoordisk A/S Stock: Q4 Profits Soar Past Expectations
Novoordisk A/S Stock: Q4 Profits Soar Past Expectations

Danish pharmaceutical giant Novoordisk A/S exceeded market expectations with an impressive 37 percent surge in fourth-quarter profits, driving its stock price up by 4.5 percent. The company's

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk


Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) and reminds investors of the